Cargando…
Wharton's Jelly Derived Mesenchymal Stem Cells: Future of Regenerative Medicine? Recent Findings and Clinical Significance
Around 5 million annual births in EU and 131 million worldwide give a unique opportunity to collect lifesaving Wharton's jelly derived mesenchymal stem cells (WJ-MSC). Evidences that these cells possess therapeutic properties are constantly accumulating. Collection of WJ-MSC is done at the time...
Autores principales: | Kalaszczynska, Ilona, Ferdyn, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377382/ https://www.ncbi.nlm.nih.gov/pubmed/25861624 http://dx.doi.org/10.1155/2015/430847 |
Ejemplares similares
-
Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
por: Gupta, Ashim, et al.
Publicado: (2020) -
Umbilical Cord-Derived Wharton’s Jelly for Regenerative Medicine Applications: A Systematic Review
por: Main, Benjamin J., et al.
Publicado: (2021) -
Regenerative Potential of the Product “CardioCell” Derived from the Wharton’s Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia
por: Musiał-Wysocka, Aleksandra, et al.
Publicado: (2019) -
Effects of Wharton’s jelly-derived mesenchymal stem cells on neonatal neutrophils
por: Khan, Imteyaz, et al.
Publicado: (2014) -
Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021)